Ch. Marth
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in ⓘ
-
- Ovarian cancer diagnosis and treatment 5
-
- Endometrial and Cervical Cancer Treatments 4
- Co-authors
- G. Daxenbichler (13 shared papers)Geertruida H. de Bock (2 shared papers)Günther Gastl (4 shared papers)Finn Bo Petersen (1 shared paper)Brigitte Eibl (1 shared paper)Anne Gächter (1 shared paper)Martin Widschwendter (6 shared papers)Lawrence R. Schiller (1 shared paper)
In The Last Decade
Ch. Marth
44 papers receiving 777 citations
Peers
Comparison fields: 5 of 79
- Hematology 277
- Immunology 289
- Obstetrics and Gynecology 99
- Oncology 235
- Reproductive Medicine 71
Countries citing papers authored by Ch. Marth
This map shows the geographic impact of Ch. Marth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Marth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Marth more than expected).
Fields of papers citing papers by Ch. Marth
This network shows the impact of papers produced by Ch. Marth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Marth. The network helps show where Ch. Marth may publish in the future.
Co-authors
The 25 scholars most cited alongside Ch. Marth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 202 | |
| 2 | 2018 | 92 | |
| 3 | 1985 | 61 | |
| 4 | 1987 | 54 | |
| 5 | 1997 | 43 | |
| 6 | Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. | 1998 | 42 |
| 7 | 2008 | 41 | |
| 8 | Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon. | 1989 | 40 |
| 9 | 1997 | 26 | |
| 10 | 1987 | 24 | |
| 11 | 1987 | 22 | |
| 12 | 1998 | 16 | |
| 13 | 1983 | 14 | |
| 14 | 1996 | 14 | |
| 15 | 1987 | 13 | |
| 16 | 1996 | 13 | |
| 17 | 1987 | 11 | |
| 18 | 2004 | 8 | |
| 19 | Interaction of retinoic acid and interferon-alpha in breast cancer cell lines. | 1996 | 8 |
| 20 | Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K. | 2001 | 7 |
About Ch. Marth
Ch. Marth is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Immunology, Transplantation and Hematology, having authored 50 papers that have together received 811 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (7 papers), Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Estrogen and related hormone effects (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (277 citations), Immunology (289 citations), Obstetrics and Gynecology (99 citations), Oncology (235 citations) and Reproductive Medicine (71 citations). Ch. Marth has collaborated with scholars based in Austria, Germany and Norway. Frequent co-authors include G. Daxenbichler, Geertruida H. de Bock, Günther Gastl, Finn Bo Petersen, Brigitte Eibl, Anne Gächter, Martin Widschwendter, Lawrence R. Schiller, H Schwaighofer and Rudolf Knapp. Their work appears in journals such as British Journal of Haematology, Cancer Letters, Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.